Amphastar Pharmaceuticals (NASDAQ:AMPH) Downgraded by StockNews.com

StockNews.com cut shares of Amphastar Pharmaceuticals (NASDAQ:AMPH – Free Report) from a buy rating to a hold rating in a research report report published on Tuesday. Separately, Bank of America began coverage on Amphastar Pharmaceuticals in a research report on Friday, November 17th. They issued a neutral rating and a $63.00 price objective on the […]

Related Keywords

China ,France ,Los Angeles ,California ,United States ,Montreal ,Quebec ,Canada ,America ,Maryz Luo , ,Exchange Traded Concepts ,Securities Exchange Commission ,News Ratings For Amphastar Pharmaceuticals Daily ,Amphastar Pharmaceuticals Inc ,Guidance Capital Inc ,Hedge Funds Weigh In On Amphastar Pharmaceuticals ,Envestnet Asset Management Inc ,Amphastar Pharmaceuticals Stock Down ,Los Angeles Capital Management ,Amphastar Pharmaceuticals ,Free Report ,Pharmaceuticals Stock Down ,Get Free Report ,Exchange Commission ,Traded Concepts ,Angeles Capital Management ,Montreal Can ,Envestnet Asset Management ,Asset Management ,Finished Pharmaceutical Products ,Active Pharmaceutical Ingredient ,Amphastar Pharmaceuticals Daily ,Nasdaq Amph ,Amph ,Medical ,Downgrade ,Stocknews Com ,